Stem Cell Therapies for Restorative Treatments of Central Nervous System Ischemia-Reperfusion Injury
- PMID: 35129759
- DOI: 10.1007/s10571-022-01204-9
Stem Cell Therapies for Restorative Treatments of Central Nervous System Ischemia-Reperfusion Injury
Abstract
Ischemic damage to the central nervous system (CNS) is a catastrophic postoperative complication of aortic occlusion subsequent to cardiovascular surgery that can cause brain impairment and sometimes even paraplegia. Over recent years, numerous studies have investigated techniques for protecting and revascularizing the nervous system during intraoperative ischemia; however, owing to a lack of knowledge of the physiological distinctions between the brain and spinal cord, as well as the limited availability of testing techniques and treatments for ischemia-reperfusion injury, the cause of brain and spinal cord ischemia-reperfusion injury remains poorly understood, and no adequate response steps are currently available in the clinic. Given the limited ability of the CNS to repair itself, it is of great clinical value to make full use of the proliferative and differentiation potential of stem cells to repair nerves in degenerated and necrotic regions by stem cell transplantation or mobilization, thereby introducing a novel concept for the treatment of severe CNS ischemia-reperfusion injury. This review summarizes the most recent advances in stem cell therapy for ischemia-reperfusion injury in the brain and spinal cord, aiming to advance basic research and the clinical use of stem cell therapy as a promising treatment for this condition.
Keywords: Cerebral ischemia–reperfusion injury; Functionally enhanced stem cells; Prototype stem cells; Spinal cord ischemia–reperfusion injury; Stem cell therapy.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury.J Vasc Surg. 2004 Jul;40(1):138-45. doi: 10.1016/j.jvs.2004.03.032. J Vasc Surg. 2004. PMID: 15218474
-
Excessively high systemic blood pressure in the early phase of reperfusion exacerbates early-onset paraplegia in rabbit aortic surgery.J Thorac Cardiovasc Surg. 2010 Aug;140(2):400-7. doi: 10.1016/j.jtcvs.2009.11.063. Epub 2010 May 27. J Thorac Cardiovasc Surg. 2010. PMID: 20537355
-
Ischemic postconditioning protects the spinal cord from ischemia-reperfusion injury via modulation of redox signaling.J Thorac Cardiovasc Surg. 2013 Sep;146(3):688-95. doi: 10.1016/j.jtcvs.2012.11.039. Epub 2012 Dec 13. J Thorac Cardiovasc Surg. 2013. PMID: 23246048
-
Development and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury.Mediators Inflamm. 2013;2013:701970. doi: 10.1155/2013/701970. Epub 2013 Jul 14. Mediators Inflamm. 2013. PMID: 23956505 Free PMC article. Review.
-
Ischemic Spinal Cord Injury-Experimental Evidence and Evolution of Protective Measures.Ann Thorac Surg. 2022 May;113(5):1692-1702. doi: 10.1016/j.athoracsur.2020.12.028. Epub 2021 Jan 9. Ann Thorac Surg. 2022. PMID: 33434541 Review.
Cited by
-
Current Advancements in Spinal Cord Injury Research-Glial Scar Formation and Neural Regeneration.Cells. 2023 Mar 9;12(6):853. doi: 10.3390/cells12060853. Cells. 2023. PMID: 36980193 Free PMC article. Review.
References
-
- Abe K (2000) Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 20:1393–1408. https://doi.org/10.1097/00004647-200010000-00001 - DOI - PubMed
-
- Alessandrini M, Preynat-Seauve O, De Bruin K, Pepper MS (2019) Stem cell therapy for neurological disorders. S Afr Med J 109:70–77. https://doi.org/10.7196/SAMJ.2019.v109i8b.14009 - DOI - PubMed
-
- Alim I, Caulfield JT, Chen Y, Swarup V, Geschwind DH, Ivanova E et al (2019) Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 177:1262-1279.e25. https://doi.org/10.1016/j.cell.2019.03.032 - DOI - PubMed
-
- Altenhöfer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P et al (2012) The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69:2327–2343. https://doi.org/10.1007/s00018-012-1010-9 - DOI - PubMed - PMC
-
- Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G et al (2011) Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134:1777–1789. https://doi.org/10.1093/brain/awr094 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
- 82001301/National Natural Science Foundation of China
- 81974019/Innovative Research Group Project of the National Natural Science Foundation of China
- 2018YFA0108700/National Key Research and Development Program of China Stem Cell and Translational Research
- 2017YFA0105602/National Basic Research Program of China (973 Program)
- 81720108004/International Science and Technology Cooperation Programme
- 201904020047/the key program of Guangzhou science research plan
- DFJHBF202111/the Special Project of Dengfeng Program of Guangdong Provincial People's Hospital
- KJ012020630/the Special Project of Dengfeng Program of Guangdong Provincial People's Hospital
- DFJH201812/the Special Project of Dengfeng Program of Guangdong Provincial People's Hospital
- KJ012019119/the Special Project of Dengfeng Program of Guangdong Provincial People's Hospital
- KJ012019423/the Special Project of Dengfeng Program of Guangdong Provincial People's Hospital
- 201704020221/the Co-innovation Foundation of Guangzhou City
LinkOut - more resources
Full Text Sources